Pancreatic Cancer Research

ResearcherConsejo Superior de Investigaciones CientíficasActive in the last 2 years

Luis Muñoz‐Bellvís

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7809-5201; OpenAlex author ID A5041120741, A5158548447. Sources: OpenAlex.

Their work

Papers
20 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
55
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 2 papers · 2019: 1 paper · 2020: 3 papers · 2021: 4 papers · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper

Papers 20

  1. Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-026-69055-2↗
  2. Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk. Co-author DOI 10.1002/ijc.35397↗
  3. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-025-65811-y↗
  4. Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mobilization of circulating tumour cells an… Co-author DOI 10.1093/bjsopen/zrae123↗
  5. HLA-A*02:01allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of theHLAvariation in PDAC Co-author DOI 10.1101/2024.08.29.24312704↗
  6. Clinical decisions in pancreatic cancer surgery: a national survey and case-vignette study. Co-author DOI 10.1007/s13304-022-01415-1↗
  7. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study. Co-author DOI 10.1097/cej.0000000000000588↗
  8. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. Co-author DOI 10.1136/gutjnl-2019-319990↗
  9. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  10. Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact. First author DOI 10.3390/cancers13174451↗
  11. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. Co-author DOI 10.1158/1055-9965.epi-19-1027↗
  12. Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients. Co-author DOI 10.20517/cdr.2019.73↗
  13. A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers12061433↗
  14. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Co-author DOI 10.1002/ijc.31866↗
  15. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. Co-author DOI 10.1093/ije/dyx269↗
  16. Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients … Last author DOI 10.1097/mcg.0000000000000793↗
  17. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk. Co-author DOI 10.1093/annonc/mdx167↗
  18. Reduced risk of pancreatic cancer associated with asthma and nasal allergies. Co-author DOI 10.1136/gutjnl-2015-310442↗
  19. Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poore… First author DOI 10.1016/j.jmoldx.2014.06.007↗
  20. Association between genetic subgroups of pancreatic ductal adenocarcinoma defined by high density 500 K SNP-arrays and tumor histopathology. First author DOI 10.1371/journal.pone.0022315↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Núria Malats · 9 shared papers, 2017–2025 · strength 0.76
  2. J. Enrique Domínguez‐Muñoz · 9 shared papers, 2017–2025 · strength 0.76
  3. Alfredo Carrato · 9 shared papers, 2017–2025 · strength 0.76
  4. William Greenhalf · 9 shared papers, 2017–2025 · strength 0.76
  5. Jorg H. Kleeff · 9 shared papers, 2017–2025 · strength 0.76
  6. Tatjana Crnogorac‐Jurcevic · 9 shared papers, 2017–2025 · strength 0.76
  7. Thomas Mathias Gress · 9 shared papers, 2017–2025 · strength 0.76
  8. Francisco X. Real · 9 shared papers, 2017–2025 · strength 0.76
  9. Matthias J. Löhr · 8 shared papers, 2017–2025 · strength 0.62
  10. Rita Teresa Lawlor · 7 shared papers, 2017–2025 · strength 0.62
  11. María Laura Gutiérrez · 6 shared papers, 2011–2021 · strength 0.59
  12. Linda Sharp · 8 shared papers, 2017–2024 · strength 0.58
  13. Bo Kong · 8 shared papers, 2017–2024 · strength 0.58
  14. Aldo Scarpa · 8 shared papers, 2017–2024 · strength 0.58
  15. Eithne Costello · 8 shared papers, 2017–2024 · strength 0.58
  16. Christoph W. Michalski · 7 shared papers, 2017–2024 · strength 0.54
  17. Paulina Gómez-Rubio · 7 shared papers, 2017–2021 · strength 0.44
  18. Alberto Órfão · 4 shared papers, 2011–2021 · strength 0.42
  19. Weimin Ye · 5 shared papers, 2018–2024 · strength 0.41
  20. Esther Molina‐Montes · 6 shared papers, 2017–2021 · strength 0.40
  21. Esteban Cugat Andorrà · 2 shared papers, 2023–2024 · strength 0.34
  22. Alberto Langtry · 2 shared papers, 2024–2025 · strength 0.32
  23. Jingru Yu · 3 shared papers, 2019–2021 · strength 0.22
  24. Mario Serradilla Martin · 1 shared paper, 2023 · strength 0.18
  25. Luis Sabater-Orti · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.